Literature DB >> 9514919

Detection of the asialoglycoprotein receptor on cell lines of extrahepatic origin.

J H Park1, E W Cho, S Y Shin, Y J Lee, K L Kim.   

Abstract

The asialoglycoprotein receptor (ASGPR) is the first lectin discovered in mammals. Despite its significant biological role in binding and internalization of desialyated glycoproteins, at least in the human, little information is available regarding its tissue distribution outside of the liver. In the present study, antibodies were raised against the H1 major subunit of the human ASGPR using synthetic peptide antigens, and their binding specificity confirmed by enzyme linked immunosorbent assay. Cell surface analysis by fluorescence activated flow cytometry on various human tissue cell lines confirmed the liver parenchymal cells as the major expression site of ASGPR. Nonetheless, ASGPR was also detectable on some extrahepatic cells such as the Jurkat T-cell line. The determination of extrahepatic expression of ASGPR will have consequences in analyzing the biological role of this receptor complex as well as having implications in designing ASGPR mediated drug- or gene-delivery strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514919     DOI: 10.1006/bbrc.1998.8256

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Bo-Ming He; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

3.  A comparison between intravenous and peritoneal route on liver targeted uptake and expression of plasmid delivered by Glyco-poly-l-lysine.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Guo-Ting Fang; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  Comparison of recombinant human haptocorrin expressed in human embryonic kidney cells and native haptocorrin.

Authors:  Evelyne Furger; Sergey N Fedosov; Dorte Launholt Lildballe; Robert Waibel; Roger Schibli; Ebba Nexo; Eliane Fischer
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.

Authors:  Daniel Rycroft; Jane Sosabowski; Edward Coulstock; Marie Davies; John Morrey; Sarah Friel; Fiona Kelly; Robert Hamatake; Milan Ovečka; Rob Prince; Laura Goodall; Armin Sepp; Adam Walker
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 6.  The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy.

Authors:  Feiyu Chen; Zhangfeng Zhong; Hor-Yue Tan; Ning Wang; Yibin Feng
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

7.  Liver-targeting of interferon-alpha with tissue-specific domain antibodies.

Authors:  Edward Coulstock; Jane Sosabowski; Milan Ovečka; Rob Prince; Laura Goodall; Clare Mudd; Armin Sepp; Marie Davies; Julie Foster; Jerome Burnet; Gráinne Dunlevy; Adam Walker
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 8.  Recent Advances in Porphyrin-Based Inorganic Nanoparticles for Cancer Treatment.

Authors:  Hanieh Montaseri; Cherie Ann Kruger; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.